206 related articles for article (PubMed ID: 24866070)
41. Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institution.
Segerhammar I; Larsson C; Nilsson IL; Bäckdahl M; Höög A; Wallin G; Foukakis T; Zedenius J
J Surg Oncol; 2012 Dec; 106(8):981-6. PubMed ID: 22674491
[TBL] [Abstract][Full Text] [Related]
42. Results of combined treatment of anaplastic thyroid carcinoma (ATC).
Derbel O; Limem S; Ségura-Ferlay C; Lifante JC; Carrie C; Peix JL; Borson-Chazot F; Bournaud C; Droz JP; de la Fouchardière C
BMC Cancer; 2011 Nov; 11():469. PubMed ID: 22044775
[TBL] [Abstract][Full Text] [Related]
43. Anaplastic thyroid carcinoma in ecuador: analysis of prognostic factors.
Pacheco-Ojeda LA; Martínez AL; Alvarez M
Int Surg; 2001; 86(2):117-21. PubMed ID: 11918236
[TBL] [Abstract][Full Text] [Related]
44. [Clinical characteristics and prognosis of anaplastic thyroid carcinoma: a 20-year single-center retrospective study].
Wei YC; Zhang D; Chai Y; Dong M
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Mar; 58(3):218-224. PubMed ID: 36878500
[No Abstract] [Full Text] [Related]
45. Long-term results of radiotherapy in anaplastic thyroid cancer.
Dumke AK; Pelz T; Vordermark D
Radiat Oncol; 2014 Mar; 9(1):90. PubMed ID: 24685141
[TBL] [Abstract][Full Text] [Related]
46. Effect of primary treatment on survival in anaplastic thyroid carcinoma.
Besic N; Auersperg M; Us-Krasovec M; Golouh R; Frkovic-Grazio S; Vodnik A
Eur J Surg Oncol; 2001 Apr; 27(3):260-4. PubMed ID: 11373102
[TBL] [Abstract][Full Text] [Related]
47. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
[TBL] [Abstract][Full Text] [Related]
48. Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years.
Brignardello E; Gallo M; Baldi I; Palestini N; Piovesan A; Grossi E; Ciccone G; Boccuzzi G
Eur J Endocrinol; 2007 Apr; 156(4):425-30. PubMed ID: 17389456
[TBL] [Abstract][Full Text] [Related]
49. Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma.
He X; Li D; Hu C; Wang Z; Ying H; Wu Y
BMC Cancer; 2014 Apr; 14():235. PubMed ID: 24690325
[TBL] [Abstract][Full Text] [Related]
50. Management of Anaplastic Thyroid Carcinoma: the Fruits from the ATC Research Consortium of Japan.
Sugitani I; Onoda N; Ito KI; Suzuki S
J Nippon Med Sch; 2018; 85(1):18-27. PubMed ID: 29540641
[TBL] [Abstract][Full Text] [Related]
51. Survival and Surgical Complications in Anaplastic Thyroid Cancer Patients After Completed Multimodal Treatment.
Lorntzsen B; Jacobsen AB; GrØholt KK; Sigstad E; Osnes T
Anticancer Res; 2020 Dec; 40(12):6979-6985. PubMed ID: 33288592
[TBL] [Abstract][Full Text] [Related]
52. Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Heikkilä A; Heiskanen I; Arola J; Haglund C
Oncology; 2010; 79(5-6):400-8. PubMed ID: 21455012
[TBL] [Abstract][Full Text] [Related]
53. Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival.
Glaser SM; Mandish SF; Gill BS; Balasubramani GK; Clump DA; Beriwal S
Head Neck; 2016 Apr; 38 Suppl 1():E2083-90. PubMed ID: 26894506
[TBL] [Abstract][Full Text] [Related]
54. Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients.
Swaak-Kragten AT; de Wilt JH; Schmitz PI; Bontenbal M; Levendag PC
Radiother Oncol; 2009 Jul; 92(1):100-4. PubMed ID: 19328572
[TBL] [Abstract][Full Text] [Related]
55. Prospective application of our novel prognostic index in the treatment of anaplastic thyroid carcinoma.
Orita Y; Sugitani I; Amemiya T; Fujimoto Y
Surgery; 2011 Dec; 150(6):1212-9. PubMed ID: 22136842
[TBL] [Abstract][Full Text] [Related]
56. A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients.
Busnardo B; Daniele O; Pelizzo MR; Mazzarotto R; Nacamulli D; Devido D; Mian C; Girelli ME
J Endocrinol Invest; 2000 Dec; 23(11):755-61. PubMed ID: 11194710
[TBL] [Abstract][Full Text] [Related]
57. [The combined treatment of anaplastic thyroid carcinoma].
Serrano M; Monroy C; Rodríguez-García JL; País JR; Fernández-Garrido M
An Med Interna; 1994 Jun; 11(6):288-90. PubMed ID: 7918941
[TBL] [Abstract][Full Text] [Related]
58. Multimodality treatment of anaplastic thyroid cancer with nearly resolved effect.
Tseng YT; Chang TC
J Formos Med Assoc; 2015 Sep; 114(9):897-8. PubMed ID: 24755268
[No Abstract] [Full Text] [Related]
59. Anaplastic thyroid carcinoma: changing trends of treatment strategies and associated overall survival.
Wächter S; Vorländer C; Schabram J; Mintziras I; Fülber I; Manoharan J; Holzer K; Bartsch DK; Maurer E
Eur Arch Otorhinolaryngol; 2020 May; 277(5):1507-1514. PubMed ID: 32060602
[TBL] [Abstract][Full Text] [Related]
60. Anaplastic thyroid carcinoma. Practical aspects of multimodal therapy and data emerging from a 40-year experience at a single Italian institution.
Baroli A; Pedrazzini L; Lomuscio G; Marzoli L
Minerva Endocrinol; 2010 Mar; 35(1):9-16. PubMed ID: 20386523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
